Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 USD | +2.61% | -3.72% | +3.61% |
06-05 | Green Thumb Reportedly Explores Merger with Boston Beer | CI |
06-05 | Boston Beer's Stock Decline Presents 'More Balanced Risk/Reward,' Morgan Stanley Says | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- With an expected P/E ratio at 49.02 and 47.45 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.61% | 2.67B | - | ||
-25.17% | 1.11B | - | ||
+47.57% | 492M | - | ||
-15.00% | 392M | - | ||
+56.81% | 198M | - | ||
+3.76% | 92.03M | - | - | |
-27.58% | 73.25M | - | ||
+40.45% | 55.55M | - | - | |
+16.25% | 53.5M | - | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GTII Stock
- GTBIF Stock
- Ratings Green Thumb Industries Inc.